Clin Mol Hepatol.  2012 Sep;18(3):268-271. 10.3350/cmh.2012.18.3.268.

Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients

Affiliations
  • 1Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea. chung50@dsmc.or.kr

Abstract

No abstract available.

Keyword

Chronic hepatitis C; Genotype 1; Ribavirin

MeSH Terms

Antiviral Agents/*therapeutic use
Female
Hepatitis C, Chronic/*drug therapy
Humans
Interferon-alpha/*therapeutic use
Male
Polyethylene Glycols/*therapeutic use
Recombinant Proteins/therapeutic use
Ribavirin/*therapeutic use
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr